Search results for "Nausea"

showing 10 items of 138 documents

Efficacy and Safety of Multiple Doses of Imab362 in Patients with Advanced Gastro-Esophageal Cancer: Results of a Phase Ii Study

2014

ABSTRACT Aim: IMAB362 is a monoclonal antibody specifically targeting claudin 18 isoform 2 (CLDN18.2), which is expressed on gastric cancer cells, whereas it is only present on a fraction of healthy stomach cells. This may reduce the risk of target-related side effects. Single-agent IMAB362 appears safe in patients with advanced gastro-esophageal cancer (GEC) based on data from a phase I trial. Methods: This international, multicenter, non-randomized phase IIa study (NCT01197885) investigated the efficacy and safety of repeated doses of IMAB362 (300 and 600 mg/m2) in patients with metastatic, refractory/recurrent, CLDN18.2-positive GEC (i.e. cancer of the stomach, the lower esophagus and th…

medicine.medical_specialtyNauseabusiness.industryPhases of clinical researchHematologyEsophageal cancermedicine.diseaseChemotherapy regimenGastroenterologyOncologyResponse Evaluation Criteria in Solid TumorsInternal medicineAnesthesiamedicineVomitingProgression-free survivalmedicine.symptomAdverse effectbusinessAnnals of Oncology
researchProduct

Diaphragmatic Hernia following Pediatric Liver Transplantation: An Underappreciated Complication Prone to Recur.

2020

Abstract Introduction Postoperative diaphragmatic hernia (DH) is a rare but potentially life-threatening complication following pediatric liver transplantation (LT). In the current literature, a total of 49 such hernias have been reported in 17 case series. We present eight additional cases, three of which reoccurred after surgical correction, and review the current literature with a focus on recurrence. Materials and Methods The study sample included children (<18 years of age) who underwent LT between June 2013 and June 2020 at five large transplant centers and who subsequently presented with DH. During the study period, a total of 907 LT was performed. Eight DH were recognized, and ri…

medicine.medical_specialtyNauseamedicine.medical_treatment030230 surgeryLiver transplantationAsymptomatic03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRecurrencemedicineHumansDiaphragmatic herniaChildRetrospective StudiesSurgical repairHernia DiaphragmaticRespiratory distressbusiness.industryInfantmedicine.diseaseSurgeryLiver TransplantationChild PreschoolPediatrics Perinatology and Child HealthVomiting030211 gastroenterology & hepatologySurgerymedicine.symptombusinessComplicationEuropean journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie
researchProduct

Adjuvant versus Neoadjuvant Radiochemotherapy for Locally Advanced Rectal Cancer A Progress Report of a Phase-III Randomized Trial (Protocol CAO/ARO/…

2001

The standard treatment for patients with clinically resectable rectal cancer is surgery. Postoperative radiochemotherapy is recommended for patients with advanced disease (pT3/4 or pN+). In recent years, encouraging results of preoperative radiotherapy have been reported. This prospective randomized phase-III trial (CAO/ARO/AIO-94) compares the efficacy of neoadjuvant radiochemotherapy to standard postoperative radiochemotherapy. We report on the design of the study and first results with regard to toxicity of radiochemotherapy and postoperative morbidity. Patients and Methods: Patients with locally advanced operable rectal cancer (uT3/4 or uN+, Mason CS III/IV) were randomly assigned to pr…

medicine.medical_specialtyNauseamedicine.medical_treatmentRectumlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawmedicineRadiology Nuclear Medicine and imagingbusiness.industryStandard treatmentPostoperative complicationTotal mesorectal excision3. Good healthSurgeryRadiation therapymedicine.anatomical_structureOncologyFluorouracil030220 oncology & carcinogenesis030211 gastroenterology & hepatologymedicine.symptombusinessmedicine.drugStrahlentherapie und Onkologie
researchProduct

Placebo and Nocebo Effects Across Symptoms: From Pain to Fatigue, Dyspnea, Nausea, and Itch

2019

Contains fulltext : 208540.pdf (Publisher’s version ) (Open Access) Placebo and nocebo effects are, respectively, the helpful and harmful treatment effects that do not arise from active treatment components. These effects have thus far been researched most often in pain. It is not yet clear to what extent these findings from pain can be generalized to other somatic symptoms. This review investigates placebo and nocebo effects in four other highly prevalent symptoms: dyspnea, fatigue, nausea, and itch. The role of learning mechanisms (verbal suggestions, conditioning) in placebo and nocebo effects on various outcomes (self-reported, behavioral, and physiological) of these different somatic s…

medicine.medical_specialtyNoceboNausealcsh:RC435-571Reviewplacebo and nocebo effectsPlacebo03 medical and health sciences0302 clinical medicinesuggestionconditioninglcsh:PsychiatryHeart ratemedicinepainitchLung functionPsychiatrybusiness.industrydyspneanausea030227 psychiatry3. Good healthNocebo EffectPsychiatry and Mental healthPhysical therapyInflammatory diseases Radboud Institute for Health Sciences [Radboudumc 5]fatigueActive treatmentmedicine.symptombusiness030217 neurology & neurosurgery
researchProduct

Impact of Palliative Care in Evaluating and Relieving Symptoms in Patients with Advanced Cancer. Results from the DEMETRA Study

2020

Background: Cancer patients experience multiple symptoms throughout the course of the disease. We aimed to provide a comprehensive analysis of the symptom burden in patients with advanced cancer at admission to specialist palliative care (PC) services and seven days later to estimate the immediate impact of PC intervention. Patient and methods: The analysis was based on an observational, prospective, multicenter study (named DEMETRA) conducted in Italy on new patients accessing network specialist PC centers during the period May 2017&ndash

medicine.medical_specialtyPalliative careNauseaHealth Toxicology and MutagenesisSymptomlcsh:MedicineDiseaseAnxietyPalliative Care.Article03 medical and health sciences0302 clinical medicineInternal medicineNeoplasmsMedicineHumansIn patient030212 general & internal medicineProspective StudiesDepression (differential diagnoses)Clinical Trials as Topicpalliative carebusiness.industrylcsh:RPublic Health Environmental and Occupational HealthCancermedicine.diseaseProspective StudieItaly030220 oncology & carcinogenesisNeoplasmAnxietyCancer patientsymptomsObservational studyFemalemedicine.symptombusinesscancer patientsHumanInternational Journal of Environmental Research and Public Health
researchProduct

The role of tapentadol as a strong opioid in cancer pain management: a systematic and critical review

2017

The aim of this review was to assess the role of tapentadol given at medium-high doses in opioid-tolerant patients for cancer pain management in place of step-3 analgesics.A systematic literature search was performed out of which six studies and one secondary analysis provided data regarding tapentadol used as a step-3 analgesic for this review. Tapentadol, when used at ≥60 mg of oral morphine equivalents in opioid-tolerant patients with cancer pain, or passing from step-2 doses to ≥60 mg of oral morphine equivalents, was well tolerated and effective and could be considered as a flexible drug to be used for the management of moderate-to-severe cancer pain. The limited occurrence of gastroin…

medicine.medical_specialtyPalliative careVomitingNauseaAnalgesicContext (language use)03 medical and health sciences0302 clinical medicinePhenolsNeoplasmsHumansMedicine030212 general & internal medicineAdverse effectIntensive care medicinePain MeasurementMorphinebusiness.industryNauseaCancer PainGeneral MedicineTapentadolAnalgesics OpioidTapentadolOpioidAnesthesiamedicine.symptombusinessCancer painConstipation030217 neurology & neurosurgerymedicine.drugCurrent Medical Research and Opinion
researchProduct

Physiopathological, Epidemiological, Clinical and Therapeutic Aspects of Exercise-Associated Hyponatremia.

2014

Exercise-associated hyponatremia (EAH) is dilutional hyponatremia, a variant of inappropriate antidiuretic hormone secretion (SIADH), characterized by a plasma concentration of sodium lower than 135 mEq/L. The prevalence of EAH is common in endurance (<6 hours) and ultra-endurance events (>6 hours in duration), in which both athletes and medical providers need to be aware of risk factors, symptom presentation, and management. The development of EAH is a combination of excessive water intake, inadequate suppression of the secretion of the antidiuretic hormone (ADH) (due to non osmotic stimuli), long race duration, and very high or very low ambient temperatures. Additional risk factors …

medicine.medical_specialtyPathologyhyponatremiaexercisebusiness.industryNausealcsh:RSIADHlcsh:MedicineGeneral MedicineReviewmedicine.diseaseHypertonic salineCerebral edemaRespiratory failureInternal medicineExercise-associated hyponatremiamedicineVomitingmedicine.symptombusinessHyponatremiahypertonic salineAntidiureticJournal of clinical medicine
researchProduct

Eine Mannitollösung als orales Kontrastmittel in der pelvinen MRT

1995

PURPOSE Improvement of pelvic MRI using peroral administration of an aqueous mannitol solution. METHODS We retrospectively evaluated magnetic resonance examinations of 72 patients with suspected or proven pelvic abnormalities: In 36 patients, no bowel marking was carried out. In further 36 patients, we performed a contrast enhancement of the bowel by oral application of 1000 ml of an aqueous mannitol solution. RESULTS 8/36 (22%) patients suffered from diarrhoea, nausea or meteorism as a result of mannitol application. In group 2, an excellent bowel marking of the small intestine could be obtained in 36/36 (100%) patients. Contrast enhancement of the bowel significantly improved delineation …

medicine.medical_specialtyPelvic MRIContrast enhancementmedicine.diagnostic_testbusiness.industryNauseadigestive oral and skin physiologyMagnetic resonance imagingSmall intestineSurgerymedicine.anatomical_structureOral administrationmedicineRadiology Nuclear Medicine and imagingMannitolmedicine.symptombusinessNuclear medicineMannitol solutionmedicine.drugRöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
researchProduct

Pure oxygen ventilation during general anaesthesia does not result in increased postoperative respiratory morbidity but decreases surgical site infec…

2014

Background. Pure oxygen ventilation during anaesthesia is debatable, as it may lead to development of atelectasis. Rationale of the study was to demonstrate the harmlessness of ventilation with pure oxygen. Methods. This is a single-centre, one-department observational trial. Prospectively collected routine-data of 76,784 patients undergoing general, gynaecological, orthopaedic, and vascular surgery during 1995–2009 were retrospectively analysed. Postoperative hypoxia, unplanned ICU-admission, surgical site infection (SSI), postoperative nausea and vomiting (PONV), and hospital mortality were continuously recorded. During 1996 the anaesthetic ventilation for all patients was changed from 30…

medicine.medical_specialtyPure oxygen ventilationLow flow ventilationSurgery and Surgical Specialtieslcsh:MedicineGeneral anesthesiaAtelectasisPostoperative hypoxiaGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundAnaesthesiology and Pain ManagementmedicineGeneral anaesthesiabusiness.industryGeneral NeuroscienceIncidence (epidemiology)lcsh:RGeneral MedicineNitrous oxideScience and Medical EducationHypoxia (medical)Vascular surgerymedicine.diseaseSurgerychemistryAnesthesiaBreathingmedicine.symptomGeneral Agricultural and Biological SciencesbusinessSurgical site infectionPostoperative nausea and vomitingPeerJ
researchProduct

ESRA19-0278 Sufentanil sublingual tablet system (SSTS) in post-operative pain: a case series

2019

Background and aims SSTS is a preprogrammed, non invasive, patient-activated bed-side system that enables patients to manage moderate-severe acute pain in a hospital setting. Our aim is to evaluate efficacy, ease of use of SSTS, patients and nurses’ satisfaction. Methods We evaluate pain control and general satisfaction in patients treated with SSTS after general or orthopedic prosthetic surgery. Enrollment started on April the 1st at Policlinico Paolo Giaccone in Palermo and is still ongoing. SSTS allows patients to self-administer a 15-μg sufentanil tablet sublingually with a 20-minute lockout, up to 72 hours. We visit patients three times per day, recording pain control (NRS scale), arte…

medicine.medical_specialtySublingual Tabletbusiness.industryNauseaAnalgesicKetorolacSufentanilBlood pressureAnesthesiaOrthopedic surgeryVomitingMedicinemedicine.symptombusinessmedicine.drugE-Poster Viewing Abstracts
researchProduct